Lisanti Capital Growth, LLC - HARMONY BIOSCIENCES HLDGS IN ownership

Back to all holdings Add to watchlist

HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 241 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q4 2022. The put-call ratio across all filers is 1.21 and the average weighting 0.7%.

Links
Filings
External links
Quarter-by-quarter ownership
Lisanti Capital Growth, LLC ownership history of HARMONY BIOSCIENCES HLDGS IN
ValueSharesWeighting
Q2 2023$1,928,412
-81.9%
54,800
-71.7%
0.27%
-81.7%
Q4 2022$10,680,033
-2.8%
193,830
-21.9%
1.46%
-0.7%
Q3 2022$10,987,000
-25.9%
248,070
-18.4%
1.47%
-27.0%
Q2 2022$14,820,000–303,865–2.01%–
 Download
Other shareholders
HARMONY BIOSCIENCES HLDGS IN shareholders Q4 2022
NameSharesValueWeighting ↓
Valor Management LLC 11,218,033$618,113,61997.50%
venBio Partners LLC 1,035,396$57,050,32017.69%
Vivo Capital, LLC 2,606,247$143,60416.53%
Nan Fung Group Holdings Ltd 368,665$20,313,44214.00%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 264,500$14,560,7254.50%
NEUMEIER POMA INVESTMENT COUNSEL LLC 685,340$37,762,2343.51%
ASHFORD CAPITAL MANAGEMENT INC 356,638$19,650,7543.05%
TANG CAPITAL MANAGEMENT LLC 281,200$15,494,1202.25%
MPM BioImpact LLC 139,377$7,679,6731.99%
O'Neil Global Advisors, Inc. 7,335$4041.86%
View complete list of HARMONY BIOSCIENCES HLDGS IN shareholders